AU2008281567B2 - Process for the preparation of alfuzosin hydrochloride - Google Patents

Process for the preparation of alfuzosin hydrochloride Download PDF

Info

Publication number
AU2008281567B2
AU2008281567B2 AU2008281567A AU2008281567A AU2008281567B2 AU 2008281567 B2 AU2008281567 B2 AU 2008281567B2 AU 2008281567 A AU2008281567 A AU 2008281567A AU 2008281567 A AU2008281567 A AU 2008281567A AU 2008281567 B2 AU2008281567 B2 AU 2008281567B2
Authority
AU
Australia
Prior art keywords
alfuzosin
process according
amino
acid
dimethoxyquinazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2008281567A
Other languages
English (en)
Other versions
AU2008281567A1 (en
Inventor
Dilip Birari
Rajendra Narayanrao Kankan
Dharmaraj Ramachandra Rao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cipla Ltd
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of AU2008281567A1 publication Critical patent/AU2008281567A1/en
Application granted granted Critical
Publication of AU2008281567B2 publication Critical patent/AU2008281567B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2008281567A 2007-08-02 2008-08-01 Process for the preparation of alfuzosin hydrochloride Ceased AU2008281567B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1493/MUM/2007 2007-08-02
IN1493MU2007 2007-08-02
PCT/GB2008/002632 WO2009016387A2 (en) 2007-08-02 2008-08-01 Process for the preparation of alfuzosin hydrochloride

Publications (2)

Publication Number Publication Date
AU2008281567A1 AU2008281567A1 (en) 2009-02-05
AU2008281567B2 true AU2008281567B2 (en) 2012-07-26

Family

ID=40304963

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2008281567A Ceased AU2008281567B2 (en) 2007-08-02 2008-08-01 Process for the preparation of alfuzosin hydrochloride

Country Status (9)

Country Link
US (1) US8716476B2 (enExample)
EP (1) EP2178864B1 (enExample)
JP (1) JP2010535185A (enExample)
KR (1) KR20100044239A (enExample)
AU (1) AU2008281567B2 (enExample)
CA (1) CA2695076A1 (enExample)
NZ (1) NZ582950A (enExample)
WO (1) WO2009016387A2 (enExample)
ZA (1) ZA201000802B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100044239A (ko) 2007-08-02 2010-04-29 시플라 리미티드 알푸조신 염산염의 제조방법
CN104893626B (zh) 2010-03-09 2017-08-08 汉高知识产权控股有限责任公司 用于压敏粘合剂的阳离子的可uv交联的丙烯酸聚合物
MX376760B (es) * 2016-02-22 2025-03-07 Hoffmann La Roche Proceso para la fabricación de derivados de 3-piperazin-1-il-propilamina.
CN113801069B (zh) * 2020-06-15 2024-03-15 鲁南制药集团股份有限公司 一种盐酸阿夫唑嗪中间体化合物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070105880A1 (en) * 2005-11-08 2007-05-10 Torrent Pharmaceuticals Limited Process for the preparation of alfuzosin
WO2007069050A2 (en) * 2005-12-16 2007-06-21 Wockhardt Ltd. Processes for the preparation of alfuzosin

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2421888A1 (fr) 1978-02-06 1979-11-02 Synthelabo Amides d'alkylene-diamines et leur application en therapeutique
YU70890A (en) 1989-04-21 1992-05-28 Egyt Gyogyszervegyeszeti Gyar Process for obtaining quinazoline derivatives
JPH07206857A (ja) 1993-12-28 1995-08-08 Synthelabo Sa アルフゾシン塩酸塩の二水和物
WO2006090268A2 (en) * 2005-02-28 2006-08-31 Glenmark Pharmaceuticals Limited Processes for the preparation of alfuzosin and salts thereof and novel crystalline forms of alfuzosin
US20070066824A1 (en) 2005-09-22 2007-03-22 Anumula Raghupathi R Preparation of alfuzosin
US20090069562A1 (en) * 2005-12-26 2009-03-12 Joseph Prabahar Koilpillai Process for the preparation of alfuzosin
WO2008114272A2 (en) 2007-03-22 2008-09-25 Cadila Healthcare Limited Process for preparing alpuzosin and crystalline alfuzosin hydrochloride
KR20100044239A (ko) 2007-08-02 2010-04-29 시플라 리미티드 알푸조신 염산염의 제조방법

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070105880A1 (en) * 2005-11-08 2007-05-10 Torrent Pharmaceuticals Limited Process for the preparation of alfuzosin
WO2007069050A2 (en) * 2005-12-16 2007-06-21 Wockhardt Ltd. Processes for the preparation of alfuzosin

Also Published As

Publication number Publication date
NZ582950A (en) 2011-06-30
WO2009016387A3 (en) 2009-07-02
US20100256370A1 (en) 2010-10-07
WO2009016387A2 (en) 2009-02-05
US8716476B2 (en) 2014-05-06
ZA201000802B (en) 2010-12-29
AU2008281567A1 (en) 2009-02-05
JP2010535185A (ja) 2010-11-18
CA2695076A1 (en) 2009-02-05
KR20100044239A (ko) 2010-04-29
EP2178864B1 (en) 2014-07-23
EP2178864A2 (en) 2010-04-28

Similar Documents

Publication Publication Date Title
EP3137083A2 (en) Novel polymorphic forms of vortioxetine and its pharmaceutically acceptable salts
JP2025502931A (ja) 薬物－リンカー複合体の調製方法
EP2178864B1 (en) Process for the preparation of alfuzosin hydrochloride
US20250197440A1 (en) Process for the preparation of a cyclic dinucleotide
CN104918912B (zh) 2‑氨基‑4,6‑二甲氧基苯甲酰胺和其他苯甲酰胺化合物的合成方法
CN107805256B (zh) 维帕他韦中间体及制备方法和应用
JP2026501936A (ja) リンカー薬物複合体の調製方法及びその中間体
WO2018032555A1 (zh) 二氢异吲哚衍生物及其类似物的制备方法
US20130085304A1 (en) Processes for preparation of polymorphic forms of lacosamide
CN118255769A (zh) 一种立体异构体的制备方法及中间体
US8093384B2 (en) Processes for the preparation of alfuzosin
EP3360865A1 (en) Process for the preparation of cyclopropyldiketopiperazines, and of a key intermediate of ds-5272
JP4356111B2 (ja) Ｎ−（２−アミノ−１，２−ジシアノビニル）ホルムアミジンの製造方法
CN111560021B (zh) 一种德高替尼中间体及其制备方法
WO2025173029A1 (en) An improved process for the preparation of deucravacitinib
WO2017081701A1 (en) An improved process for the preparation of thalidomide
US20120184751A1 (en) Polymorphic form of olmesartan medoxomil
CN121991162A (zh) 一种药物偶联物中间体及制备方法
CN119859139A (zh) 双盐酸安罗替尼的固体形式及其制备方法
CN111943894A (zh) 一种4,7-二氮杂螺[2.5]辛烷类化合物的合成方法

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired